Hiding in Plain Sight: Why Sleep Apnea Goes Undetected for Years in Women and Older Adults

A Diagnosis Built Around the Wrong Patient

For decades, the clinical picture of obstructive sleep apnea was drawn almost exclusively from studies conducted on middle-aged, overweight men. That original portrait became the default template—loud, disruptive snoring, witnessed breathing pauses, daytime sleepiness so profound a patient could fall asleep mid-conversation. It was a compelling picture, but it was incomplete. And that incompleteness has carried a real cost for the millions of patients who don't fit that mold.

Today, sleep apnea affects an estimated 30 million Americans, yet researchers believe that up to 80 percent of moderate to severe cases remain undiagnosed. Within that undiagnosed population, women and older adults are disproportionately represented. Understanding why requires looking honestly at both the biology of the condition and the structural biases that have shaped how medicine approaches it.

Why Women's Symptoms Are Frequently Dismissed

Women with sleep apnea rarely present the way the textbooks describe. Rather than the stereotypical thunderous snoring and gasping episodes, women are more likely to experience what clinicians call atypical symptoms: persistent fatigue that doesn't improve with rest, morning headaches, difficulty concentrating, low mood, irritability, and a general sense of feeling unwell. These symptoms are real, measurable, and disruptive—but they also overlap significantly with conditions like depression, anxiety, hypothyroidism, and perimenopause.

The result is a diagnostic detour. A woman in her forties who reports exhaustion and mood changes is far more likely to leave her physician's office with a referral for mental health support or a thyroid panel than with an order for a sleep study. That is not a failure of care in any individual instance—it is a failure of pattern recognition at the systems level. When clinicians are not trained to consider sleep apnea as a primary suspect in this symptom constellation, the investigation simply doesn't begin.

Hormones also play a meaningful biological role. Progesterone and estrogen have protective effects on upper airway muscle tone and respiratory drive. As those hormone levels decline during perimenopause and postmenopause, the physiological protection against airway collapse diminishes. Studies have shown that postmenopausal women have a prevalence of sleep apnea comparable to that of men of similar age—yet referral rates for sleep evaluation in this group remain substantially lower.

The Older Adult Diagnostic Gap

For adults over 65, the challenge is different but equally significant. Sleep apnea becomes increasingly common with age, driven by changes in upper airway anatomy, reduced muscle tone, and shifts in sleep architecture. Yet in this population, the condition is routinely misattributed to the normal consequences of aging.

An older patient who reports poor sleep quality, nighttime awakenings, and cognitive fog may hear that these are simply expected changes that come with getting older. While some sleep changes are indeed age-related, untreated sleep apnea is not a benign inconvenience—it is a serious medical condition associated with elevated cardiovascular risk, accelerated cognitive decline, increased fall risk, and diminished quality of life. Accepting it as inevitable aging forecloses treatment that could meaningfully improve both longevity and daily function.

Additionally, older adults frequently take multiple medications, some of which—including sedatives, muscle relaxants, and certain cardiac drugs—can worsen sleep-disordered breathing. This polypharmacy complexity can obscure the underlying diagnosis and make symptom interpretation more challenging for both patients and providers.

The Atypical Warning Signs Worth Knowing

Because the classic presentation is not universal, it is worth familiarizing yourself with the less-recognized indicators of sleep apnea that tend to appear more frequently in women and older adults:

• Unrefreshing sleep: Waking after a full night's rest feeling as though you haven't slept at all is a meaningful signal, not simply a personality trait or stress response.
• Nocturia: Waking repeatedly during the night to urinate is often assumed to reflect a bladder or prostate issue. In many cases, however, it is a direct consequence of the physiological stress that apnea events place on the cardiovascular system.
• Morning headaches: Recurrent headaches upon waking, particularly across the forehead, can indicate nighttime oxygen desaturation.
• Mood and cognitive changes: Irritability, difficulty with memory and focus, and symptoms resembling depression or anxiety that do not fully respond to standard treatment may warrant sleep evaluation.
• Witnessed gasping versus snoring: Women with sleep apnea are more likely to gasp or choke than to snore loudly, meaning a bed partner's report may sound less dramatic but is no less clinically significant.

What to Advocate for During Your Clinical Visit

If you recognize yourself in the descriptions above, there are concrete steps you can take to ensure a thorough evaluation.

Be specific about your sleep history. Rather than describing yourself as tired, bring detailed observations: how many times you wake at night, whether you feel rested in the morning, whether you have headaches upon waking, and whether anyone has noted unusual breathing patterns during your sleep.

Request consideration of a sleep study. Both in-laboratory polysomnography and home sleep apnea tests are available options. Your physician can help determine which is appropriate based on your clinical picture. Do not hesitate to ask directly whether sleep-disordered breathing has been considered as a contributing factor to your symptoms.

Discuss your hormonal status if relevant. For women in perimenopause or postmenopause, explicitly raising the connection between hormonal changes and sleep apnea risk can be an important part of the conversation.

Bring a sleep diary. Tracking your sleep patterns, symptoms, and nighttime experiences for one to two weeks prior to your appointment gives your physician concrete data to work with and signals that you are approaching the concern systematically.

Ask about your cardiovascular and metabolic risk profile. Sleep apnea is independently associated with hypertension, atrial fibrillation, type 2 diabetes, and stroke. If you carry any of these diagnoses or risk factors, that context strengthens the clinical rationale for evaluation.

The Stakes of Getting This Right

Sleep apnea is treatable. Continuous positive airway pressure therapy, oral appliances, positional interventions, and in select cases surgical options can substantially reduce the burden of the disease. Patients who receive appropriate treatment frequently describe transformative improvements in energy, cognition, mood, and cardiovascular markers.

But treatment can only follow diagnosis. And diagnosis depends on both a clinician's willingness to look beyond the standard profile and a patient's willingness to advocate clearly for a thorough investigation.

If you have been living with persistent fatigue, unexplained mood changes, poor sleep quality, or morning headaches—and those concerns have not yet led to a conversation about sleep-disordered breathing—it may be time to raise the question directly. Your symptoms deserve a complete answer, not an assumption.